Allergan plc Company Profile (NYSE:ACT)

About Allergan plc

Allergan plc logoActavis, Inc. formerly Watson Pharmaceuticals, Inc., is a integrated global specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand, biosimilar and over-the-counter (OTC) pharmaceutical products. The Company also develops and out-licenses generic pharmaceutical products primarily in Europe through its Medis third-party business. The Company operates in three segments: Actavis Pharma, Actavis Specialty Brands and Anda Distribution. On January 23, 2013, the Company completed the acquisition of Uteron Pharma SA. On October 29, 2012, the Company sold its Rugby OTC pharmaceutical products and trademarks to The Harvard Drug Group, L.L.C. On January 24, 2012, the Company completed the acquisition of Ascent Pharmahealth Ltd.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: ACT
  • CUSIP: 00507K10
Key Metrics:
  • Previous Close: $299.00
  • 50 Day Moving Average: $297
  • 200 Day Moving Average: $285
  • 52-Week Range: $202.00 - $318.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 14.24
  • P/E Growth: 0
  • Market Cap: $N/A
Additional Links:
Companies Related to Allergan plc:

Analyst Ratings

Consensus Ratings for Allergan plc (NYSE:ACT) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $270.00 (9.70% downside)

Analysts' Ratings History for Allergan plc (NYSE:ACT)
Show:
DateFirmActionRatingPrice TargetDetails
3/28/2016Leerink SwannBoost Price TargetOutperform$180.00 -> $215.00View Rating Details
11/2/2015SusquehannaBoost Price TargetPositive$290.00 -> $325.00View Rating Details
6/4/2015Bank of America Corp.Set Price TargetBuy$350.00View Rating Details
6/3/2015Raymond James Financial Inc.Initiated CoverageOutperform$344.00View Rating Details
5/29/2015Deutsche Bank AGBoost Price TargetBuy$336.00 -> $343.00View Rating Details
5/29/2015Canaccord GenuityReiterated RatingBuy$352.00View Rating Details
5/28/2015Citigroup Inc.Initiated CoverageFocus List -> Focus List$360.00View Rating Details
5/11/2015GuggenheimSet Price TargetBuy$345.00 -> $355.00View Rating Details
5/8/2015Barclays PLCSet Price TargetHold$300.00View Rating Details
5/8/2015MizuhoInitiated CoverageBuy$358.00View Rating Details
4/8/2015Royal Bank Of CanadaReiterated RatingPositive$361.00View Rating Details
3/24/2015Sterne Agee CRTReiterated RatingBuy$315.00 -> $340.00View Rating Details
3/18/2015BMO Capital MarketsBoost Price TargetBuy$286.00 -> $373.00View Rating Details
3/17/2015Goldman Sachs Group Inc.Initiated CoverageBuy$365.00View Rating Details
3/11/2015JPMorgan Chase & Co.Initiated CoverageOverweight$310.00 -> $375.00View Rating Details
3/6/2015Edward JonesInitiated CoverageBuyView Rating Details
2/25/2015Sanford C. BernsteinBoost Price TargetOutperform$315.00 -> $350.00View Rating Details
2/20/2015ArgusBoost Price TargetBuy$310.00 -> $340.00View Rating Details
2/19/2015CRT CapitalSet Price TargetBuy$288.00 -> $315.00View Rating Details
12/4/2014Morgan StanleyBoost Price TargetOverweight$266.00 -> $315.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Allergan plc (NYSE:ACT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2015        
5/11/2015Q115$3.84$4.30$4.04 billion$4.23 billionViewListenView Earnings Details
2/18/2015Q414$3.67$3.91$3.84 billion$4.01 billionViewN/AView Earnings Details
11/5/2014Q314$3.10$3.19$3.63 billion$3.68 billionViewN/AView Earnings Details
8/5/2014Q214$3.36$3.42$2.55 billion$2.67 billionViewN/AView Earnings Details
4/30/2014Q114$3.23$3.49$2.59 billion$2.66 billionViewListenView Earnings Details
2/20/2014Q413$3.05$3.17$2.68 billion$2.78 billionViewListenView Earnings Details
10/29/2013Q313$2.09$2.09$2.04 billion$2.01 billionViewListenView Earnings Details
7/25/2013Q2 2013$2.00$2.01$1.99 billion$1.99 billionViewListenView Earnings Details
5/2/2013Q1 2013$1.86$1.99$1.97 billion$1.90 billionViewListenView Earnings Details
2/19/2013Q4 2012$1.53$1.59$1.74 million$1.75 billionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Allergan plc (NYSE:ACT)
Current Year EPS Consensus Estimate: $18 EPS
Next Year EPS Consensus Estimate: $21 EPS

Dividends

Dividend History for Allergan plc (NYSE:ACT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Allergan plc (NYSE:ACT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/9/2015Nesli BasgozDirectorSell2,200$297.89$655,358.00View SEC Filing  
11/26/2014William MeuryInsiderSell4,550$269.14$1,224,587.00View SEC Filing  
9/8/2014Albert Paonessa IIIInsiderSell6,642$230.49$1,530,914.58View SEC Filing  
9/16/2013Albert HummelDirectorSell6,200$137.81$854,422.00View SEC Filing  
9/4/2013George Fred WilkinsonInsiderSell16,749$138.00$2,311,362.00View SEC Filing  
9/4/2013Jack MichelsonDirectorSell6,064$139.54$846,170.56View SEC Filing  
8/29/2013David BuchenInsiderSell10,000$135.56$1,355,600.00View SEC Filing  
8/26/2013Albert HummelDirectorSell40,000$134.44$5,377,600.00View SEC Filing  
8/20/2013Paul BisaroCEOSell50,000$135.30$6,765,000.00View SEC Filing  
8/15/2013Albert Paonessa IIIInsiderSell5,476$135.89$744,133.64View SEC Filing  
8/14/2013R Todd JoyceCFOSell15,000$137.98$2,069,700.00View SEC Filing  
8/13/2013Albert HummelDirectorSell10,000$133.85$1,338,500.00View SEC Filing  
8/12/2013Cathy KlemaDirectorSell1,667$133.03$221,761.01View SEC Filing  
8/12/2013David BuchenInsiderSell17,000$133.03$2,261,510.00View SEC Filing  
8/9/2013Ronald TaylorDirectorSell5,000$135.14$675,700.00View SEC Filing  
8/5/2013Charles EbertVPSell8,244$136.25$1,123,245.00View SEC Filing  
8/5/2013Michel FeldmanDirectorSell10,000$136.94$1,369,400.00View SEC Filing  
8/2/2013Robert StewartInsiderSell14,564$136.02$1,980,995.28View SEC Filing  
3/14/2013Charles M MayrInsiderSell1,000$91.77$91,770.00View SEC Filing  
3/12/2013Michael J FedidaDirectorSell8,000$89.00$712,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Allergan plc (NYSE:ACT)
DateHeadline
investopedia.com logoGet Major Biotechs With BBH ETF (BBH) - Investopedia (NYSE:ACT)
www.investopedia.com - September 30 at 8:03 AM
prnewswire.com logoAllergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals - PR Newswire (press release) (NYSE:ACT)
www.prnewswire.com - September 29 at 3:16 PM
News IconAllergan PLC (AGN) stock trades up, "Buy" rating reiterated at Goldman Sachs Group Inc. - BNB Daily (blog) (NYSE:ACT)
www.baseball-news-blog.com - September 29 at 8:03 AM
businesswire.com logoTeva Announces Launch of Generic Epzicom® Tablets in the United States - Business Wire (press release) (NYSE:ACT)
www.businesswire.com - September 28 at 3:16 PM
prnewswire.com logoAllergan to Present New Data at the American Urogynecologic Society Annual Meeting in Denver - PR Newswire (press release) (NYSE:ACT)
www.prnewswire.com - September 27 at 3:17 PM
marketrealist.com logoThis Strategy Could Boost Teva’s Growth Prospects Even More (NYSE:ACT)
marketrealist.com - September 27 at 3:17 PM
News IconCompetition, Generics Not Always Limiting Drug Costs | Bloomberg ... - Bloomberg BNA (NYSE:ACT)
www.bna.com - September 27 at 7:22 AM
News IconPfizer Will Not Split Into 2 Firms - DTN The Progressive Farmer (registration) (blog) (NYSE:ACT)
www.dtnpf.com - September 26 at 3:16 PM
thestreet.com logoRead Scraps Pfizer Break-up As Megadeals Escape Its Grasp (NYSE:ACT)
www.thestreet.com - September 26 at 3:16 PM
News IconBusiness Journal Honors Innovators - Orange County Business Journal (NYSE:ACT)
www.ocbj.com - September 23 at 3:42 PM
finance.yahoo.com logoBig trade buys time for gains in Allergan (NYSE:ACT)
finance.yahoo.com - September 23 at 3:42 PM
News IconThe OSG and More Potential Cases for 2016 (NYSE:ACT)
empiricalscotus.com - September 23 at 8:05 AM
News IconBiotech Stocks Worth a Closer Look: Agenus Inc. (NASDAQ:AGEN), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE) - The Voice Registrar (NYSE:ACT)
voiceregistrar.com - September 22 at 3:17 PM
News IconActive Stocks' Revenge with Bears- Advanced Micro Devices (NASDAQ:AMD), Tobira Therapeutics (TBRA), Air ... - Seneca Globe (NYSE:ACT)
www.senecaglobe.com - September 22 at 3:17 PM
thestreet.com logoGilead Sciences (GILD) Stock Lower Despite Bullish Gabelli Note (NYSE:ACT)
www.thestreet.com - September 22 at 3:16 PM
moodys.com logoMoody's: Regulatory, political event risks remain for US drug companies; geographic and product diversity to help ... - Moodys.com (press release) (subscription) (NYSE:ACT)
www.moodys.com - September 22 at 8:37 AM
streetinsider.com logoForm 6-K TEVA PHARMACEUTICAL INDU For: Sep 22 - StreetInsider.com (NYSE:ACT)
www.streetinsider.com - September 22 at 8:37 AM
News IconBusiness Highlights - CNSNews.com (NYSE:ACT)
www.cnsnews.com - September 22 at 8:37 AM
finance.yahoo.com logoNorth America Opioid Market Analysis By Product, By Application ... - Yahoo Finance (NYSE:ACT)
finance.yahoo.com - September 22 at 8:37 AM
wsj.com logo[$$] Big Pharma’s Big Checkbooks Drive Biotech Resurgence (NYSE:ACT)
www.wsj.com - September 22 at 8:37 AM
thestreet.com logoJim Cramer's Top Takeaways: Flex, Walt Disney, Allergan (NYSE:ACT)
www.thestreet.com - September 22 at 8:37 AM
News IconMEG WHITMAN raising for TIM KAINE -- TOM STEYER ups the ante by $20 million -- CALIFORNIA's public-company ... - Politico (NYSE:ACT)
www.politico.com - September 21 at 3:44 PM
News IconBusiness Highlights - SFGate (NYSE:ACT)
www.sfgate.com - September 21 at 3:44 PM
investorplace.com logoS&P 500 Remains in a Holding Pattern | InvestorPlace - Investorplace.com (NYSE:ACT)
investorplace.com - September 21 at 3:44 PM
seekingalpha.com logoAllergan: Examining The Premiums Paid - Seeking Alpha (NYSE:ACT)
seekingalpha.com - September 21 at 3:44 PM
wsj.com logo[$$] Big Pharma's Big Checkbooks Drive Biotech Resurgence (NYSE:ACT)
www.wsj.com - September 21 at 3:43 PM
blogs.barrons.com logoBiotech: Why NASH is So Hot Right Now (NYSE:ACT)
blogs.barrons.com - September 21 at 3:43 PM
News IconAllergan Acquires Akarna Therapeutics Adding to its Strong Development Program and (NYSE:ACT)
www.biomedreports.com - September 21 at 10:39 AM
News IconAllergan Acquires Akarna Therapeutics Adding to its Strong Development Program and Commitment to Innovation in NASH (NYSE:ACT)
www.kait8.com - September 21 at 10:39 AM
prnewswire.com logoRegeneron and Teva Announce Global Collaboration to Develop ... - PR Newswire (press release) (NYSE:ACT)
www.prnewswire.com - September 20 at 3:19 PM
uk.finance.yahoo.com logoUS STOCKS-Wall St buoyed by healthcare with Fed on deck (NYSE:ACT)
uk.finance.yahoo.com - September 20 at 3:19 PM
feeds.benzinga.com logoNASH Sympathy Plays On Tobira Therapeutics Deal (NYSE:ACT)
feeds.benzinga.com - September 20 at 3:16 PM
investorplace.com logoAllergan plc Ordinary Shares: What Is AGN Getting for Its Billion Dollars? (NYSE:ACT)
investorplace.com - September 20 at 11:23 AM
businesswire.com logoTeva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational ... - Business Wire (press release) (NYSE:ACT)
www.businesswire.com - September 20 at 9:03 AM
finance.yahoo.com logoAllergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH - Yahoo Finance (NYSE:ACT)
finance.yahoo.com - September 20 at 9:03 AM
finance.yahoo.com logoAllergan could pay up to a 1,800% premium to acquire a tiny pharmaceutical company (NYSE:ACT)
finance.yahoo.com - September 20 at 9:03 AM
finance.yahoo.com logoUS STOCKS-Wall St set to open higher as investors await Fed meet (NYSE:ACT)
finance.yahoo.com - September 20 at 9:03 AM
News IconLocal legislators took in more than $50,000 from companies that fought against rules curbing opioid abuse (NYSE:ACT)
www.timesnews.net - September 19 at 4:08 PM
businesswire.com logoTeva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease - Business Wire (press release) (NYSE:ACT)
www.businesswire.com - September 19 at 8:04 AM
News IconLocal legislators took in more than $50000 from companies that fought against rules curbing opioid abuse - Kingsport Times News (NYSE:ACT)
www.timesnews.net - September 19 at 8:04 AM
News IconHC Stocks Summary! Allergan plc Ordinary Shares (AGN), Juno Therapeutics Inc (NASDAQ:JUNO) - share market updates (press release) (NYSE:ACT)
sharemarketupdates.com - September 19 at 8:04 AM
barrons.com logoWill Bayer's Takeover of Monsanto Be a Bust? - Barron's - Barron's (NYSE:ACT)
www.barrons.com - September 17 at 3:17 PM
businesswire.com logoNational Business Group on Health Honors Teva Pharmaceuticals with Best Employers for Healthy Lifestyles® Award - Business Wire (press release) (NYSE:ACT)
www.businesswire.com - September 17 at 8:04 AM
barrons.com logo[$$] Will Bayer's Takeover of Monsanto Be a Bust? (NYSE:ACT)
www.barrons.com - September 17 at 8:04 AM
News IconHC Stocks Review= Mylan NV (NASDAQ:MYL), Allergan plc ... - share market updates (press release) (NYSE:ACT)
sharemarketupdates.com - September 16 at 3:17 PM
finance.yahoo.com logoNational Business Group on Health Honors Teva Pharmaceuticals with Best Employers for Healthy Lifestyles® Award - Yahoo Finance (NYSE:ACT)
finance.yahoo.com - September 16 at 11:58 AM
bizjournals.com logoHow do you price drugs fairly? Cameron Durrant has some ideas — BioFlash podcast (NYSE:ACT)
feeds.bizjournals.com - September 16 at 10:35 AM
News IconHC Stocks Impression= Vitae Pharmaceuticals Inc (VTAE), Great Basin Scientific Inc (NASDAQ:GBSN) - share market updates (press release) (NYSE:ACT)
sharemarketupdates.com - September 15 at 3:17 PM
News IconNational Business Group on Health Honors Teva Pharmaceuticals with Best Employers for Healthy Lifestyles® Award - Yahoo Sports (NYSE:ACT)
sports.yahoo.com - September 15 at 3:17 PM
News IconMix Wondering Stocks- Acasti Pharma Inc. (NASDAQ:ACST), CommScope Holding (COMM), Vitae Pharmaceuticals ... - Seneca Globe (NYSE:ACT)
www.senecaglobe.com - September 15 at 12:08 PM

Social

Allergan plc (NYSE:ACT) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff